Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03111914 · ClinicalTrials.gov registry record · NA
Applications of Dual Energy CT in Patients With Osseous Metastases From Castrate-resistant Prostate Cancer
A NA study, sponsored by Duke University.
- Terminated
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT03111914 is a NA study that was terminated before completion, run by Duke University. The registered enrollment target is 7 participants.
The verdict
NCT03111914, a NA study, was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
The purpose of this study is to establish a more accurate and precise way to image (take pictures of) metastatic bone disease in patients with prostate cancer for staging and monitoring response to therapy. More specifically, the study aims to evaluate the capabilities of dual energy CT as a more precise and accurate tool for staging and monitoring of therapy response in patients with osseous metastases from castrate-resistant prostate cancer. Bone metastases in prostate cancer patients are a clinical and diagnostic challenge to image. Sometimes very small metastatic bone lesions may only become detectable by imaging in response to therapy due to increased bone deposition during the first three months after therapy. Commonly used imaging tests (such as regular CT or bone scan) are unable to reliably tell the difference between increased bone deposition (therapy response) and growth of the lesion (progressive disease). This diagnostic challenge may have profound negative effects on patient management since it may require additional imaging before an accurate determination of tumor response can be made. An appropriate determination of tumor response is needed for appropriate management of prostate cancer. The investigators anticipate that the new imaging tested in this study (called dual energy CT) may provide additional critical information in this clinical and diagnostic challenge. Approximately 100 people with prostate cancer and metastatic bone disease will take part in this study. At enrollment, three months, and six months, they will will receive a non-enhanced (without contrast) dual energy CT scan of the chest, abdomen and pelvis before receiving their routine, clinical contrast-enhanced CT scan.
Interventions
- DIAGNOSTIC_TEST Dual Energy Computed Tomography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2017-07-03 |
| Est. Completion | 2017-10-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03111914
The ClinicalTrials.gov registry entry for NCT03111914 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dual Energy Computed Tomography is the first listed.
NCT03111914 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03111914 about?
NCT03111914 is a clinical study titled "Applications of Dual Energy CT in Patients With Osseous Metastases From Castrate-resistant Prostate Cancer". The purpose of this study is to establish a more accurate and precise way to image (take pictures of) metastatic bone disease in patients with prostate cancer for staging and monitoring response to therapy. More specifically, the study aims to evaluate the capabilities of dual energy CT as a more pr...
What is the current status of trial NCT03111914?
This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2017-07-03. Estimated completion is 2017-10-09.
What interventions are being tested in trial NCT03111914?
The interventions under investigation include: Dual Energy Computed Tomography (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03111914?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.